1Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R.Iran.
2Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I. R. Iran
3Department of Clinical Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, I. R. Iran
4Isfahan Pharmaceutical Sciences Research Center, Isfahan, I. R. Iran
5School of Medicine, Isfahan University of Medical Sciences, Isfahan, I. R. Iran
Objective: Anti-inflammatory, immuno-modulatory, and antioxidant properties of Moringa oleifera Lam. suggest that it might have beneficial effects on colitis. The present study was performed to investigate the anticolitis effect of Moringa oleifera seeds hydro-alcoholic extract (MSHE) and its chloroform fraction (MCF) on acetic acid-induced colitis in rats. Materials and Methods: Both MSHE and MCF with three increasing doses (50, 100, and 200 mg/kg) were administered orally to separate groups of male Wistar rats, 2 h before ulcer induction (using acetic acid 4%) and continued for 5 days. Prednisolone (4 mg/kg) and normal saline (1 ml/kg) were used in reference and control groups, respectively. All rats were sacrificed 24 h after the last dose (at day 6) and tissue injuries were assessed macroscopically and pathologically. Results: Extracts with three doses mentioned before were effective to reduce weight of distal colon (8 cm) as a marker for inflammation and tissue edema. Three doses of MSHE and two greater doses of MCF (100 and 200 mg/kg) were effective to reduce ulcer severity, area, and index as well as mucosal inflammation severity and extent, crypt damage, invasion involvement, total colitis index, and MPO activity compared with controls. MCF (50 mg/kg) was not significantly effective in reducing evaluated parameters of colitis compared with controls. Conclusion: It is concluded that MSHE and MCF were both effective to treat experimental colitis and this might be attributed to their similar major components, biophenols and flavonoids. Since the efficacy was evident even in low doses of MSHE, presence of active constituents with high potency in seeds is persuasive.
Anwar F, Latif S, Ashraf M, Gilani AH. 2007. Moringa oleifera Lam.: a food plant with multiple medicinal uses. Phytother Res, 21: 17-25.
Caceres A, Saravia A, Rizzo S, Zabala L, Leon ED, Nave F. 1992. Pharmacologic properties of Moringa oleifera. 2: Screening for antispasmodic, anti-inflammatory and diuretic activity. Ethnopharmacol, 36: 233-237.
Cooper HS, Murthy SNS, Shah RS, Sedergran DJ. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest, 69: 238-249.
Dieleman LA, Palmen MJHJ, Akol H, Bloemena E, Pena AS, Meuwissen SGM. 1998. Chronic experimental colitis induced by dextran sulfate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol, 114: 385-391.
Fahey JW. 2005. Moringa oleifera: A review of the medical evidence for its nutritional, therapeutic, and prophylactic properties. Tree Life J, 1: 1-15.
Frankel EN, Meyer AS. 2000. The problems of using one-dimensional methods to evaluate multifunctional food and biological antioxidants. J Sci Food Agric, 80: 1925-1941.
Ghassemi-Dehkordi N. 2002. Matricaria. In: Iranian Herbal Pharmacopoeia Scientific Committee (Eds), pp. 25-26, 99-107, Tehran, Iran Ministry of Health & Medical Education Publications.
Ghia JE, Blennerhassett P, Collins SM. 2007. Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol, 293: 560-567.
Gholap PA, Nirmal SA, Pattan SR, Pal SC, Mandal SC. 2012. Potential of Moringa oleifera root and Citrus sinensis fruit rind extracts in the treatment of ulcerative colitis in mice. Pharm Biol, 50: 1297-1302.
Heim KE, Tagliaferro AR, Bobilya DJ. 2002. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem, 13: 572-584.
Koneni VS, Jammikuntla N, Rakesh S, Ram R, Siron MR. 2009. Rare dipeptide and urea derivatives from roots of Moringa oleifera as potential anti-inflammatory and antinociceptive agents. Eur J Med Chem, 44: 432-436.
MacPherson BR, Pfeiffer CJ. 1978. Experimental production of diffuse colitis in rats. Digestion, 17: 135-150.
Maisuthisakul P, Suttajit M, Pongsawatmanit R. 2007. Assessment of phenolic content and free radical-scavenging capacity of some Thai indigenous plants. Food Chem, 100: 1409-1418.
Matsuda H, Ochi M, Nagatomo A, Yoshikawa M. 2007. Effects of allyl isothiocyanate from horseradish on several experimental gastric lesions in rats. Eur J Pharmacol, 561: 172-181.
McQuaid KR. 2007. Drugs used in the treatment of gastrointestinal disease. In: Katzung, BG (Ed). Basic and Clinical Pharmacology. pp. 1029-1035, New York, McGraw Hill Companies.
Mehta A, Agrawal B. 2008. Investigation into the mechanism of action of Moringa oleifera for its anti-asthmatic activity. Orient Pharm Exp Med, 8: 24-31.
Minaiyan M, Ghassemi-Dehkordi N, Mahzouni P, Ansari-Roknabady M. 2011. Effect of Matricaria aurea (Loefl.) Shultz-Bip. hydroalcoholic extract on acetic acid-induced colitis in rats. Iran J Basic Med Sci, 14: 67-74.
Minaiyan M, Ghannadi AR, Mahzouni P, Nabi-Meibodi M. 2008. Anti-ulcerogenic effect of Ginger (rhizome of Zingiber officinale Roscoe) hydroalcoholic extract on acetic acid –induced acute colitis in rats. Res Pharm Sci, 3: 79-86.
Minaiyan M, Ghannadi AR, Karimzadeh A. 2006. Antiulcerogenic effects of ginger (Zingiber officinale Roscoe) on cysteamine induced duodenal ulcer in rats. Daru, 14: 97-101.
Montoro P, Braca A, Pizza C, De Tommasi N. 2005. Structure-antioxidant activity relationships of flavonoids isolated from different plant species. Food Chem, 92: 349-355.
Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. 1989. Hapten induced model of inflammation and ulceration in rat colon. Gasteroenterol, 96: 795-803.
Motavallian A, Minaiyan M, Rabbani M, Mahzuni P. 2012. Anti-inflammatory effect of ondansetron through 5-HT3 receptors on TNBS-induced colitis in rat. Exp Clin J, 11: 30-44.
Murata Y, Ishiguru Y, Itoh J, Munakata A, Yoshida Y. 1995. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gasteroenterol, 30: 56-60.
Sartor RB. 1997. Pathogenesis and immune mechanism of chronic inflammatory bowel diseases. Am J Gastroenterol, 92: 5-11.
Sellin JH, Pasricha PJ. 2006. Pharmacotherapy of inflammatory bowel diseases. In: Brunton LL, Lazo JS, Parker KL (Eds) Goodman and Gilmans’ the Pharmacological Basis of Therapeutics. pp. 1009-1011, New York, McGraw-Hill companies.
Shaheen E, Annette K. 2011. Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J Transl Med, 9: 129.
Shaila G, Mahjan, Anita A. 2010. Immunosuppresive activity of ethanolic extract of seeds of Moringa oleifera Lam. in experimental immune inflammation. Ethnopharmacol Commun, 130: 183-186.
Siddhuraju P, Becker K. 2003. Antioxidant properties of various solvent extracts of total phenolic constituents from three different agroclimatic origins of drumstick tree (Moringa oleifera Lam.) leaves. J Agric Food Chem, 51: 2144-2155.
Verma AR,Vijayakumar M, Mathela CS, Rao CV. 2009. In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves. Food Chem Toxicol, 47: 21196-21201.